Literature DB >> 29663726

Preparing the key metabolite of Z-ligustilide in vivo by a specific electrochemical reaction.

Feipeng Duan1, Wenjuan Xu1, Jie Liu1, Zhixin Jia1, Kuikui Chen1, Yijun Chen1, Mingxia Wang1, Kaiyue Ma1, Jiaojiao Dong1, Lianming Chen1, Hongbin Xiao1,2.   

Abstract

The key in vivo metabolites of a drug play an important role in its efficacy and toxicity. However, due to the low content and instability of these metabolites, they are hard to obtain through in vivo methods. Electrochemical reactions can be an efficient alternative to biotransformation in vivo for the preparation of metabolites. Accordingly, in this study, the metabolism of Z-ligustilide was investigated in vitro by electrochemistry coupled online to mass spectrometry. This work showed that five oxidation products of the electrochemical reaction were detected and that two of the oxidation products (senkyunolide I and senkyunolide H) were identified from liver microsomal incubation as well. Furthermore, after intragastric administration of Z-ligustilide in rats, senkyunolide I and senkyunolide H were detected in the rat plasma and liver, while 6,7-epoxyligustilide, a key intermediate metabolite of Z-ligustilide, was difficult to detect in vivo. By contrast, 6,7-epoxyligustilide was obtained from the electrochemical reaction. In addition, for the first time, 6 mg of 6,7-epoxyligustilide was prepared from 120 mg of Z-ligustilide. Therefore, electrochemical reactions represent an efficient laboratory method for preparing key drug metabolites.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  6,7-epoxyligustilide; Z-ligustilide; electrochemistry; liver microsomal incubation; metabolites

Mesh:

Substances:

Year:  2018        PMID: 29663726     DOI: 10.1002/jssc.201800164

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  CaMKII, that binds with ligustilide, as a potential drug target of Suxiao jiuxin pill, a traditional Chinese medicine to dilate thoracic aorta.

Authors:  Yujie Lu; Jie Ji; Simeng Chu; Fukui Shen; Wen Yang; Wei Lei; Min Jiang; Gang Bai
Journal:  Clin Transl Med       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.